Rising Incidents of Chronic Diseases is Fostering the Demand for Immunoassay Market Globally

Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetic and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of wide range of analytes in biological samples.

As per UnivDatos Market Insights, the Immunoassay Market is expected to register a CAGR of 7% during the forecast period (2021-2027). The surge in the market is on account of the rising incidents of chronic diseases. More than a million cancer cases are diagnosed every year and as per the American Cancer Society (2021), 1 in 3 people will be diagnosed with cancer in their lifetime. The report “Immunoassay Market: Current Analysis and Forecast (2020-2027)” by UnivDatos Market Insights deliver a comprehensive analysis of the Technology, Specimen, Product, Application, and End-Users, and Region/Country

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=12333

Based on Technology, the market is fragmented into Immunoassay, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Radio-Immuno Assay, and Other Technologies. The Enzyme-Linked Immunospot segment dominated the market in 2020 and is expected to grow at lucrative growth.

Based on Specimen, the market is fragmented into Blood, Saliva, Urine, and Other Specimens. The Blood segment dominated the market in 2020 owing to the surging number of blood donations and the increasing incidence of chronic and infectious diseases worldwide. As per the WHO, of the 118.5 million blood donations collected globally, 40% of these are collected in high-income countries, home to 16% of the world’s population.

Based on Applications, the market is fragmented into Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, and Other Applications. The Infectious Diseases segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period owing to a rise in the incidence of infectious diseases such as HIV, malaria, influenza, and the novel COVID-19. As per UNAIDS, six in seven new HIV infections among adolescents aged 15–19 years are among girls in sub-Saharan Africa. Young women aged 15–24 years are twice as likely to be living with HIV than men.

Based on Product, the market is bifurcated into Reagents & Kits, and Analyzers. The Reagents & Kits segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period owing to high demand for immunoassay reagents and kits for diagnosis purposes with the growing prevalence of infectious and autoimmune diseases.

Based on End Users, the market is fragmented into Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Blood Banks, Research & Academic Laboratories, and Home Care Settings. The Hospitals and Clinics segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period owing to high testing volumes. In addition, the rise in the number of hospitals also drives market growth. Moreover, hospitals & clinics work as reference laboratories to small hospitals and physician offices.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=12333

North America is expected to hold Lion’s Share

Based on regions, the report provides detailed analysis for overall demand of In-Vehicle Infotainment System for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, South Korea, Rest of Asia-Pacific); and Rest of World. North America is expected to dominate the Immunoassay market on account of increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region.

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Immunoassay Management Market are Thermofisher Scientific, bioMérieux SA, Abbott Laboratories, Danaher Corporation (Beckman Coulter), Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, and F. Hoffmann-La Roche AG In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany). This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.

§?In February 2021, Thermo Fisher Scientific Inc. acquired the private point-of-care molecular diagnostic company Mesa Biotech

§?In January 2021, Abbott received the CE Mark for its Panbio COVID-19 Ag Rapid Test Device, for the asymptomatic diagnosis of the SARS-CoV-2 virus. It also offers self-swabbing

§?In December 2020, Beckman Coulter, the part of Danaher (US) company, launched the first high-quality and throughput assay called Access SARS-CoV-2 Antigen assay, for the COVID-19 antigen diagnosis, in the US

§?In October 2020, Thermo Fisher Scientific launched its EliA SARS-CoV-2-Sp1 IgG test and OmniPATH COVID-19 Total Antibody ELISA test, for the diagnosis of COVID-19 antibodies

“Immunoassay Management Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go to market strategies and identifying the blue ocean for its offerings.?????

For more informative information, please visit us @ https://univdatos.com/report/immunoassay-market/

Market Segmentation:

1.?????By Technology (Immunoassay, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Radio-Immuno Assay, and Other Technologies)

2.?????By Specimen (Blood, Saliva, Urine, and Other Specimens)

3.?????By Applications (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, and Other Applications)

4.?????By Product (Reagents & Kits, and Analyzers)

5.?????By End-users (Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Blood Banks, Research & Academic Laboratories, and Home Care Settings)

6.?????By Region (North America, Europe, Asia-Pacific, Rest of the World)

7.?????By Company (Thermofisher Scientific, bioMérieux SA, Abbott Laboratories, Danaher Corporation (Beckman Coulter), Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, and F. Hoffmann-La Roche AG)

Key questions answered in the study:

1.?????What are the current and future trends of the Immunoassay industry?

2.?????How the industry has been evolving in terms of Technology, Specimen, Product, Application, and End-Users, and Region/Country?

3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.?????What are the key growth drivers and challenges for the Immunoassay industry?

5.?????What are the customer orientation, purchase behavior, and expectations from the Immunoassay firms across various regions??